Lassa fever has impacted populations across African nations for decades.
What are the clinical and epidemiological dynamics behind this critical tropical disease?
@jvatitd.bsky.social
@jvatitd.bsky.socialLassa fever has impacted populations across African nations for decades.
What are the clinical and epidemiological dynamics behind this critical tropical disease?
@gmj-georgia.bsky.socialBreaking: Two early-phase clinical trials for Lassa fever vaccine and therapeutics now underway—the first human testing of treatment in 20+ years. Natur… #Clinicalresearch #Lassafever #Vaccinetrials #Viralhemorrhagicfever #WestAfrica #Clinicalresearch #Lassafever #Vaccinetrials #Viralhemorrhagi…
@jvatitd.bsky.social
@vaccinologist.bsky.socialResearchers at @cornellupress.bsky.social developed a portable point-of-care test that can help distinguish #Ebola vs. #Lassafever using a finger-prick blood sample. A test strip detects viral proteins, while the PROVIDS reader analyzes the result in under 5 seconds. www.linkedin.com/posts/drmelv...
@enclai.netAlertX verified 1,056 Lassa fever cases in Nigeria over the last 12 months.
Live map → enclai.net/map
#Epidemiology #GlobalHealth #IDsky #LassaFever #Nigeria
@dit-journal.bsky.social#LassaFever remains a global health challenge.
This review highlights emerging #antivirals, #MonoclonalAntibodies, and combination therapies that could outperform ribavirin and improve stage-specific treatment.
@healthlawadamh.bsky.socialInteresting article on #LassaFever :
"When Lassa Fever Travels: Lessons From a Nosocomial Outbreak in Guinea" academic.oup.com/jid/article/...